Wet Macular Degeneration Drug May Reduce Number of Injections Needed

An experimental drug, AXT107, may one day make treatment simpler for patients with age-related macular degeneration, according to research published in the January 18 issue of Science Translational Medicine.

“We anticipate injection of AXT107 in humans may have a substantially longer effect than current treatment,” lead researcher Peter Campochiaro, MD, a professor of ophthalmology at the Johns Hopkins University in Baltimore, told HealthDay. “Instead of eye injections every four to six weeks, we hope it would be several months between injections.”

 For more Info:
http://www.empr.com/news/macular-degeneration-blocking-vascular-endothelial-growth-factor/article/632633/
http://www.newsmax.com/Health/Health-News/drug-sight-stealing-disease-age-related/2017/01/19/id/769339/
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: